Musa et al
Greener Journal of Epidemiology and Public Health Vol. 2 (1), pp. 032-036, July 2014.
ISSN: 2354-2381 © 2013 Greener Journals
Manuscript Number: 042214195
Studies on Cytomegalovirus Infection among HIV Positive Patients Attending Infectious Diseases Hospital, Kano State, Nigeria
*1Musa AM, 2Taura DW, 3Mukhtar MD, 4Koki YA, 5Adamu S
1,4Pathology Department, Murtala Muhammad Specialist Hospital, Kano, Nigeria.
2,3Department of Microbiology, Bayero University, Kano, Nigeria.
5Department of Pharmacy, Infectious Diseases Hospital, Kano, Nigeria.
*Corresponding Author’s Email: mabdullahi262 @gmail .com, +2348039598826
Cytomegalovirus is a virus of paradoxes and can be a potential killer or a silent lifelong companion. The CMV infection in immunocompromised patients carries high morbidity and mortality. CMV infection is a common opportunistic viral infection among HIV/AIDS patients. This research therefore aimed at Studying Cytomegalovirus infection among HIV Positive Patients Attending Infectious Diseases Hospital, Kano, to ascertain the seroprevalence of specific CMV IgM antibodies among HIV positive patients and to correlate the infection rate with immune status (CD+4count) of the patients. A total of 207 clients who were reactive to HIV-1/HIV-2 antibodies were enrolled in the study. Sera samples were screened serologically for the presence of specific CMV IgM antibodies by using microwell ELISA kits manufactured by Immunodiagnostics Inc. Out of 207 HIV positive patients, 27 (13.0%) were seroreactive to the specific CMV IgM antibodies of which 9 (4.3%) were males and 18 (8.7%) were females. Patients with low CD+4 lymphocyte(< 100 cells/μl) were more infected by CMV.-High seroprevalence of specific CMV IgM antibodies was found among HIV patients and therefore monitoring of HIV patients with low CD+4 counts for the presence of specific CMV IgM antibodies may be of paramount importance to identify those at risk of CMV disease so as to carry prophylactic treatment before they develop clinical manifestation of CMV disease (end organ disease).
Keywords: CD+4 Cells, Cytomegallovirus, Human Immunodef
Akinbami, AA, Akanmu, AS, Adeyemo, TA, Wright, KO Dada, MO, Dosunmi, AO (2010). Cytomegalovirus Antibodies among Immunocompromised (HIV) Patients at Lagos University Teaching Hospital (LUTH) Idi Araba, Lagos.J. Medicine 151 – 154.
Akinsola, FB, Okany, CC, Majekodunmi, AA and Akinsete, I (1997).Ocular Manifestations of HIV Infections in Lagos University Teaching Hospital.The Nigerian Postgraduate Medical Journal.4 (3).
Basawaraju, A, Pratibha, MM, Vijayadurga, S (2011): The Reactivation of Cytomegalovirus (CMV) Infection in HIV Infected Patients. Journal of Clinical and Diagnostic Research.5: 749 – 51.
Chakravarti, A, Kashyap, B, Metlani, M (2009). Cytomegalovirus Infections: An Indian Perspective. Indian J. Med. Microbiology; 27: 3 – 11.
Chakravarti, A, Tewari, S, Bhalla, P (2010). Human Cytomegalo Infection among Patients Living with AIDS in a Tertiary Level Hospital in India. Journal of the International Association of Physicians in AIDS Care; 9: 94 – 7.
Cheesbrough, M (2005). Human Immunodeficiency Virus, District Laboratory Practice in Tropical Countries. Pat 2 2ndedition Cambridge University Press. Pp. 253 – 55.
Cunha, AA, Marrin, LJ, Aquino, VH, Figuiredo, LT (2002). Diagnosis of Cytomegalovirus infections by qualitative and quantitative Polymerase Chain Reacyion in HIV Infected patients.Dev Inst.Me.Trop. Saopolo,44:127-32Pp.
Hizal, K, Danks, DM, Gibas, H and Jack, I (1972).Cytomegalovirus in Human Milk.N. Engl. J. Med. 287: 117 – 178.
Klatt, EC, Shibata, D (1988).Cytomegalovirus Infection in the Acquired Immunodeficinecy Syndrome.Clinical and Antopsy Findings.Arch Pathol Lab Med; 112: 540 – 44.
Krech, U (1973). Complement – Fixing Antibodies Against Cytomegalovirus in Different Parts of the World Bull World Health Organ: 49: 103 – 6.
Lab test online (2012). The test of Cytomegalovirus.American Association of Clinical Chemistry.www.labtestonline.org.
Mujtaba, S, Varma, S and Sehgal, S (2003). Cytomegalovirus Co – infection in Patients with HIV/AIDS in North India. Indian J. Med. Pes; 117: 99 – 103.
Neto, WC, Rubin, R, Shulte, J and Guigliani, R (2004).Newborn Screening for Congenital Infections Disease. Emergence Infection Disease; 1 (6): 1069 – 1073.
Neusa, M Antonio, F and Incilia, C (1998).Research of Antigen and Antibodies from Retrovirus, CMV, and HBV among Prisoners of Pententiary Complex of the Region of Comparinces. S.P. Brazil. Rev. Int. Med. Trop. S. Paulo: 40 (4).
Nishimura, N, Kimura, H, Rabuta, Y, Tanaka, N, Ishikawa, K, Suzuki, C, and Morishin, T (1999). Prevalence of Material Cytomegalovirus (CMV) antibody and Detection of CMV DNA in Amniotic Fluid.Medical Immunol. 43 (8): 781 – 784.
Okwori, EJ, Olabode, AO, Emumwem, EG, Lugos, MO, Okpe, ES, Okopi, JA and Adetunji, JA (2008). Seroepidemiological Survey of Human CytomegalovirusInfection among Expectant Mothers in Bida Nigeria. Journal of Infections Disease;6:2.
Ryan, KJ and Ray, CG (2004).Sherris Medical Microbiology.4th ed., McGraw Hill, Pp. 556; 566 – 9.
Springer, KL, Weinberg, A (2004). Cytomegalovirus Infection in the era of HAART: Fewer Reactivation and More Immunity. Journal of Antimicrobial Chemotherapy. 45: 582 – 586.
srtsvadze, T, Gochitashvili, N, Sharvadze, L, Dvali, N (2002): Cytomegalovirus Infection in HIV Patients. International Conference on AIDS.Infections Disease; AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.1 – 2.
Turbadkar, D, Mathur, M, and Dele, M (2000). Seroprevalence of TORCH Infection in Bad Obstetric.Indian J. Med Microbiology:21 (2): 108 – 110.
Zhong, XX and Ma, TY (1999). A Clinical Study of Cytomegalovirus Infection During Pregnancy J. Med. Univ.; 13: 60 – 4.